How a single dose of a study medicine moves through the body in people with different kidney function
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a single dose of an investigational medicine (NNC0537-1482) to see how it moves through the body in people with different levels of kidney function. It may help researchers understand how the drug is processed so it can be dosed safely in future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old (implied by phase 1, but not explicitly listed; we omit age as it's not in criteria).
- Your body mass index (BMI) must be between 18.5 and 39.9.
- You must have either normal kidney function or a certain level of chronic kidney disease (mild, moderate, severe, or end-stage requiring dialysis).
- If you have kidney disease, you must have had it for at least 3 months.
- If you are on dialysis, you must have been on hemodialysis for at least 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called EC5026 in people with and without chronic kidney disease (CKD) to see how the body handles it. It helps understand if dose adjustments are needed for people with impaired kidney function.
This study tests different doses of an investigational medicine (NNC0519-0130) to see if it can reduce kidney damage in people with chronic kidney disease. It may be an option for you if you have kidney impairment and either have or don't have type 2 diabetes.
This trial tests an investigational drug called HRS-1780 in people with chronic kidney disease. It aims to see if the drug can help slow kidney decline and is safe to use.
This study tests a new medicine, SAL0140, at different doses to see if it can help people with chronic kidney disease. It may reduce protein in the urine, which is a sign of kidney damage.
This study tests a new daily pill (called HRS-7535) that may help protect kidney function in people with chronic kidney disease. It works like a natural hormone to help control blood sugar and reduce inflammation, and the researchers want to see if it can slow down kidney damage.
This study looks at how the kidneys work in both healthy people and those with reduced kidney function. Researchers want to understand kidney health better to help people in the future.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.